137 related articles for article (PubMed ID: 35726155)
1. Spontaneous xenogeneic GvHD in Wilms' tumor Patient-Derived xenograft models and potential solutions.
Monzavi SM; Muhammadnejad A; Behfar M; Khorsand AA; Muhammadnejad S; Kajbafzadeh AM
Animal Model Exp Med; 2022 Dec; 5(4):389-396. PubMed ID: 35726155
[TBL] [Abstract][Full Text] [Related]
2. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents.
Verma B; Wesa A
Curr Protoc Pharmacol; 2020 Jun; 89(1):e77. PubMed ID: 32453514
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous Post-Transplant Disorders in NOD.Cg- Prkdcscid Il2rgtm1Sug/JicTac (NOG) Mice Engrafted with Patient-Derived Metastatic Melanomas.
Radaelli E; Hermans E; Omodho L; Francis A; Vander Borght S; Marine JC; van den Oord J; Amant F
PLoS One; 2015; 10(5):e0124974. PubMed ID: 25996609
[TBL] [Abstract][Full Text] [Related]
4. A human model of xenogeneic graft-versus-host disease in SCID mice engrafted with human peripheral blood lymphocytes.
Sandhu JS; Gorczynski R; Shpitz B; Gallinger S; Nguyen HP; Hozumi N
Transplantation; 1995 Jul; 60(2):179-84. PubMed ID: 7624960
[TBL] [Abstract][Full Text] [Related]
5. Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice.
Ehx G; Somja J; Warnatz HJ; Ritacco C; Hannon M; Delens L; Fransolet G; Delvenne P; Muller J; Beguin Y; Lehrach H; Belle L; Humblet-Baron S; Baron F
Front Immunol; 2018; 9():1943. PubMed ID: 30214443
[TBL] [Abstract][Full Text] [Related]
6. CD8-positive lymphocytes in graft-versus-host disease of humanized NOD.Cg-Prkdc(scid)Il2rg(tm1Wjl)/SzJ mice.
Laing ST; Griffey SM; Moreno ME; Stoddart CA
J Comp Pathol; 2015; 152(2-3):238-42. PubMed ID: 25670669
[TBL] [Abstract][Full Text] [Related]
7. Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation.
Dieter SM; Giessler KM; Kriegsmann M; Dubash TD; Möhrmann L; Schulz ER; Siegl C; Weber S; Strakerjahn H; Oberlack A; Heger U; Gao J; Hartinger EM; Oppel F; Hoffmann CM; Ha N; Brors B; Lasitschka F; Ulrich A; Strobel O; Schmidt M; von Kalle C; Schneider M; Weichert W; Ehrenberg KR; Glimm H; Ball CR
Int J Cancer; 2017 Mar; 140(6):1356-1363. PubMed ID: 27935045
[TBL] [Abstract][Full Text] [Related]
8. [Establishment of an xenogeneic acute graft-versus-host disease model in NOD/SCID mice by engraftment of G-CSF mobilized human mononuclear cells].
Gao L; Wang JM; Xie LN; Zhou H; Qiu HY
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):87-91. PubMed ID: 18681307
[TBL] [Abstract][Full Text] [Related]
9. PRO 140 Monoclonal Antibody to CCR5 Prevents Acute Xenogeneic Graft-versus-Host Disease in NOD-scid IL-2Ry
Burger DR; Parker Y; Guinta K; Lindner D
Biol Blood Marrow Transplant; 2018 Feb; 24(2):260-266. PubMed ID: 29128556
[TBL] [Abstract][Full Text] [Related]
10. Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.
Pino S; Brehm MA; Covassin-Barberis L; King M; Gott B; Chase TH; Wagner J; Burzenski L; Foreman O; Greiner DL; Shultz LD
Methods Mol Biol; 2010; 602():105-17. PubMed ID: 20012395
[TBL] [Abstract][Full Text] [Related]
11. Characterization of EBV-related lymphoproliferative lesions arising in donor lymphocytes of transplanted human tumor tissues in the NOG mouse.
Fujii E; Kato A; Chen YJ; Matsubara K; Ohnishi Y; Suzuki M
Exp Anim; 2014; 63(3):289-96. PubMed ID: 25077758
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood.
Gorin NC; Piantadosi S; Stull M; Bonte H; Wingard JR; Civin C
J Hematother Stem Cell Res; 2002 Apr; 11(2):277-92. PubMed ID: 11983099
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Th17-Polarized Human CD4
Delens L; Ehx G; Somja J; Vrancken L; Belle L; Seidel L; Grégoire C; Fransolet G; Ritacco C; Hannon M; Dubois S; Beguin Y; Baron F; Servais S
Biol Blood Marrow Transplant; 2019 Feb; 25(2):204-215. PubMed ID: 30326279
[TBL] [Abstract][Full Text] [Related]
14. A novel immunodeficient rat model supports human lung cancer xenografts.
He D; Zhang J; Wu W; Yi N; He W; Lu P; Li B; Yang N; Wang D; Xue Z; Zhang P; Fan G; Zhu X
FASEB J; 2019 Jan; 33(1):140-150. PubMed ID: 29944447
[TBL] [Abstract][Full Text] [Related]
15. The status of donor cancer tissues affects the fate of patient-derived colorectal cancer xenografts in NOG mice.
Fujii E; Kato A; Chen YJ; Matsubara K; Ohnishi Y; Suzuki M
Exp Anim; 2015; 64(2):181-90. PubMed ID: 25740629
[TBL] [Abstract][Full Text] [Related]
16. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
Chen Y; Zhang R; Wang L; Correa AM; Pataer A; Xu Y; Zhang X; Ren C; Wu S; Meng QH; Fujimoto J; Jensen VB; Antonoff MB; Hofstetter WL; Mehran RJ; Pisimisis G; Rice DC; Sepesi B; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Heymach JV; Fang B
Cancer; 2019 Nov; 125(21):3738-3748. PubMed ID: 31287557
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice.
Nervi B; Rettig MP; Ritchey JK; Wang HL; Bauer G; Walker J; Bonyhadi ML; Berenson RJ; Prior JL; Piwnica-Worms D; Nolta JA; DiPersio JF
Exp Hematol; 2007 Dec; 35(12):1823-38. PubMed ID: 17764813
[TBL] [Abstract][Full Text] [Related]
18.
Chandra S; Cristofori P; Fonck C; O'Neill CA
Toxicol Pathol; 2019 Jul; 47(5):656-660. PubMed ID: 31064282
[TBL] [Abstract][Full Text] [Related]
19. Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models.
Okada S; Vaeteewoottacharn K; Kariya R
Cells; 2019 Aug; 8(8):. PubMed ID: 31412684
[TBL] [Abstract][Full Text] [Related]
20. Xenogeneic graft-versus-host-disease in NOD-scid IL-2Rγnull mice display a T-effector memory phenotype.
Ali N; Flutter B; Sanchez Rodriguez R; Sharif-Paghaleh E; Barber LD; Lombardi G; Nestle FO
PLoS One; 2012; 7(8):e44219. PubMed ID: 22937164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
